Site Search
Mayo Clinic Laboratories releases new, first-to-U.S.-market pregnancy risk assessment - Insights
Mayo Clinic Laboratories now offers the first preeclampsia-specific test (Mayo ID: PERA) that can be used to stratify patients into low or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe...
Research Suggests Genetics Are Key in Treating Night Sweats - Insights
Hormone therapy is often used to prevent night sweats. But finding the right dose of estrogen can be tricky, with some women needing more estrogen than others to get relief. A new Mayo Clinic study published in Menopause: The Journal of the...
Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D. - Insights
Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique assay identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal...
Adrenal Gland Tumors: Stefan Grebe, M.D., Ph.D., and Irina Bancos, M.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Stefan Grebe, M.D., Ph.D., co-director of the Clinical Mass Spectrometry and Test Development...
Mayo Clinic Laboratory and Pathology Research Roundup: July 9 - Insights
This week’s Research Roundup highlights the association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.
Collaboration that changes lives: Elyn Simmons - Insights
Working together, Mayo Clinic laboratory medicine specialists and clinicians helped Elyn Simmons get her life back — and welcome two new lives to the world.
Learn how Mayo Clinic Laboratories testing for adrenal diseases can help physicians detect and classify adrenal disorders.
Improving diagnosis and treatment of Helicobacter pylori - Insights
Mayo Clinic Laboratories now offers a noninvasive approach for the molecular detection of H. pylori, with results that include prediction of clarithromycin resistance delivered within 24 hours.
Ova and parasite testing - Insights
Learn about our ova and parasite test and its role as a fundamental laboratory method to detect parasitic helminths and protozoa in stool specimens.
Tick-borne coinfection - Insights
Browse our suite of serological and molecular testing designed to detect tick-borne pathogen coinfections.
IMPACTS Team Continues to Combat Life-Threatening Arthropod-Borne Infections in Belize - Insights
Now in its second year of a five-year initiative to better understand and detect arboviruses in Belize, the IMPACTS (Integrated Mayo Clinic Program for Arbovirus Community health education Training and Surveillance) project has expanded its...
Bobbi Pritt, M.D., on Asian Longhorned Tick in U.S - Insights
According to the Centers for Disease Control and Prevention (CDC), the Asian longhorned tick has spread across nine states since it first appeared in the U.S. Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory and...
Laboratory Utilization Management: Tick-Borne Disease Testing - Insights
In this month's "Hot Topic," Elitza Theel, Ph.D., will be discussing laboratory utilization management, specifically for diagnostic testing for tick-borne diseases.
Insect-borne disease - Insights
Find out more about our targeted approach to testing for the various diseases carried by a number of different insect species.
Diagnosing Lyme Disease: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to...
Dengue Virus: A Diagnostic Testing Update - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., talks about Mayo Clinic Laboratories’ serologic and molecular testing for the identification of infection with dengue virus. Dengue virus poses a significant public health threat worldwide....
Elitza Theel, Ph.D., Director of the Infectious Diseases Serology Laboratory, discusses eastern equine encephalitis virus, which is spread via mosquito bite.
Bobbi Pritt, M.D., Comments on Blacklegged Ticks in Minnesota Conservation Volunteer - Insights
Blacklegged ticks (also known as deer ticks) are turning up more frequently in Minnesota, and so are the diseases they carry. Bobbi Pritt, a parasitologist in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester,...
Trends in the Laboratory and Diagnostic Testing Market: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They cover current...
Learn the ABCs of ticks - Insights
Protect yourself and your family from infectious insects During the summer months, the great outdoors can be a wonderland for exploration. But some of
Learn how our cystatin C testing provides an index of glomerular filtration rate, which is the best indicator of overall kidney health and function.
A team of Mayo Clinic pathologists have discovered a new tissue biomarker, DNAJB9, for fibrillary glomerulonephritis, a rare kidney disease of unknown pathogenesis and poor outlook—nearly half of all patients end up on dialysis within four...
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 13 - Insights
This week’s Research Roundup highlights how the DnaJ heat shock protein family B member 9 is a novel biomarker for fibrillary GN.
Mayo Clinic Researchers Develop Prediction Tool for Kidney Stones - Insights
Mayo Clinic researchers are tracking the familiar characteristics of kidney stone formers in an online prediction tool that could help sufferers anticipate if they'll experience future episodes.
Mayo Clinic Laboratory and Pathology Research Roundup: May 28 - Insights
This week’s Research Roundup highlights the clinical and pathology findings associated consistently with larger glomerular volume.
Mayo Clinic Laboratory and Pathology Research Roundup: June 12 - Insights
This week’s Research Roundup highlights noninvasive assessment of renal fibrosis with magnetization transfer MR imaging.
Mayo Clinic Laboratory and Pathology Research Roundup: Dec. 3 - Insights
This week’s Research Roundup highlights predicting renal function outcomes after partial and radical nephrectomy.
The National Kidney Foundation, the American Society for Clinical Pathology, and the nation’s leading laboratories and clinical laboratory societies have announced a new collaboration to remove barriers to testing for chronic kidney...
There have been concerns in the U.S. recently about the possible harmful side effects from absorbing gadolinium-based contrast agents into the body during some MRI exams. To address some of the anxiety and concerns over this issue, Paul...
Mayo Clinic Laboratory and Pathology Research Roundup: Dec. 10 - Insights
This week’s Research Roundup highlights the evaluation of monoclonal gammopathy of renal significance: A consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
A collaborative study between Mayo Clinic and the University of Illinois debunked the previous consensus about how kidney stones grow.
Membranous nephropathy - Insights
Membranous nephropathy (MN) is one of the leading causes of nephrotic syndrome in adults. Our menu of clinically validated assays assists with diagnosis, monitors disease progression, and guides clinical outcomes.
Find out why testing for anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies is recommended for differential diagnosis.
Antibody against the GABA-A receptor is a biomarker of autoimmune encephalopathy that occurs across the lifespan, and disproportionately affects children. In this test-specific episode of the "Answers From the Lab" podcast, Andrew McKeon,...
The discovery of Kelch like protein 11 (KLHL11) IgG as a specific biomarker of neurological autoimmunity associated testicular germ cell tumor.
Whole genome sequencing streamlines diagnosis - Insights
Nicole Boczek, Ph.D., and Sarah Barnett, M.S., CGC, explain how Mayo Clinic Laboratories' whole genome sequencing provides comprehensive information for rapid diagnosis of hereditary disorders.
Divyanshu Dubey, M.B.B.S., explains how Mayo Clinic Laboratories' unique PDE10A and TRIM46 tests facilitate the management of central nervous system disorders triggered by cancers. Early diagnosis and treatment are important for managing...
Shining light on one family's struggle: Barbara, Deborah, Pamela, and Rylie - Insights
Before testing at Mayo Clinic Laboratories, Barbara Domaille, Deborah Neville, Pamela Neville, and Rylie Ronnenberg thought there could be a genetic connection to the hip problems they shared. After the testing, they knew for sure.
Unraveling a diagnostic mystery: Ed Garber - Insights
Ed Garber spent months in physical and neurological decline while a cohort of care providers and specialists searched for the root cause of his symptoms. That search for answers ended after testing by Mayo Clinic Laboratories gave them the...
Autoimmune Epilepsy Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune epilepsy contains only clinically relevant antibodies providing accurate answers for treatment guidance.
Predictors to Direct Neural Antibody Testing in Autoimmune Encephalitis/Epilepsy - Insights
In this “Hot Topic,” Divyanshu Dubey, M.B.B.S., associate professor of laboratory medicine and pathology and neurology at Mayo Clinic, discusses various clinical and paraclinical features of autoimmune encephalitis, autoimmune seizures, and...
Zhiyv (Neal) Niu, Ph.D., and Christopher Klein, M.D., explain how Mayo Clinic Laboratories' updated neuromuscular gene panel informs diagnosis and treatment. The phenotype-based panel covers the complete list of neuromuscular genes and...
A "sandbox" for innovation: The Advanced Diagnostics Laboratory - Insights
Mayo Clinic’s Advanced Diagnostics Laboratory (ADL) is a visionary space designed to foster innovation. The ADL has a direct impact on patient lives, bringing promising tests and services to patients at Mayo and around the world.
Mayo Clinic Labs @Work: Rehab Elkadri - Insights
Rehab Elkadri joined Mayo Clinic Laboratories in December 2021, relocating from the United Kingdom to the United Arab Emirates. As an international clinical specialty liaison in the Neurology division for the Middle East and North Africa...
Mayo Clinic Labs @Work: Ona Saras - Insights
As a clinical specialty representative, Ona Saras’ decade-long dedication to patient care and advocacy for cutting-edge testing at Mayo Clinic Laboratories has transformed lives across Northern California and Reno, Nevada. Through personal...
Invasive fungal infection - Insights
Mayo Clinic Laboratories’ fungal biomarker test rapidly screens for invasive fungal infections caused by various fungal pathogens.
Histoplasma/Blastomyces - Insights
Mayo Clinic Laboratories full menu of testing for Histoplasma or Blastomyces infection includes an innovative, direct detection assay can detect antigens from both species.
Mayo Clinic Laboratories upfront, screening enzyme-linked immunosorbent assay detects Coccidioides antibodies prior to testing by complement fixation (CF) or immunodiffusion (ID). Samples that result as reactive by are subsequently reflexed...
Find out how our Candida auris polymerase chain reaction assay detects and identifies C. auris from surveillance swabs.
Endemic fungal infections in North America: Elitza Theel, Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic,...